Concepedia

Joshua Reardon

JR

7

Publications

393

Citations

7

H-Index

1980

Active since

Affiliations

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute(Current)

The Ohio State University

The Ohio State University Wexner Medical Center

Joshua Reardon is an author at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute specializing in medicine, pathology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

1980–2022

7

Publications

7

Neoadjuvant Modified (m) FOLFIRINOX for Locally Advanced Unresectable (LAPC) and Borderline Resectable (BRPC) Adenocarcinoma of the Pancreas

Marlo Blazer, Christina Wu, Richard M. Goldberg et al. · Annals of Surgical Oncology · 2014 · 249 citations · Full text

, , +10

A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis

Daniel H. Ahn, Kavya Krishna, Marlo Blazer et al. · Therapeutic Advances in Medical Oncology · 2016 · 53 citations · Full text

Gemcitabine-Associated Thrombotic Microangiopathy: Response to Complement Inhibition and Reinitiation of Gemcitabine

Jeffrey L. Turner, Joshua Reardon, Tanios Bekaii‐Saab et al. · Clinical Colorectal Cancer · 2016 · 24 citations

, , +6

Comparison of conventional versus liposomal irinotecan in combination with fluorouracil for advanced pancreatic cancer: a single-institution experience

Justin Tossey, Joshua Reardon, Jeffrey VanDeusen et al. · Medical Oncology · 2019 · 23 citations · Full text

, , +7

Implementation and early outcomes for a surgeon‐directed hepatic arterial infusion pump program for colorectal liver metastases

Jeffery Chakedis, Eliza W. Beal, Steven Sun et al. · Journal of Surgical Oncology · 2018 · 18 citations

Rows per page

1–5 of 7